These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 11232753

  • 1. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.
    Gomez JC, Crawford AM.
    J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753
    [Abstract] [Full Text] [Related]

  • 2. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ, Roychowdhury SM, Milton DR, Hill AL.
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD.
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
    Jones B, Taylor CC, Meehan K.
    J Clin Psychiatry; 2001 Jan; 62 Suppl 2():22-4. PubMed ID: 11232747
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S.
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [Abstract] [Full Text] [Related]

  • 7. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD, Sanger TM.
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [Abstract] [Full Text] [Related]

  • 8. Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.
    Dossenbach MR, Kratky P, Schneidman M, Grundy SL, Metcalfe S, Tollefson GD, Belmaker RH.
    J Clin Psychiatry; 2001 Apr; 62 Suppl 2():28-34. PubMed ID: 11232749
    [Abstract] [Full Text] [Related]

  • 9. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.
    Hamilton SH, Revicki DA, Genduso LA, Beasley CM.
    Neuropsychopharmacology; 1998 Jan; 18(1):41-9. PubMed ID: 9408917
    [Abstract] [Full Text] [Related]

  • 11. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
    Tollefson GD, Sanger TM, Lu Y, Thieme ME.
    Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219
    [Abstract] [Full Text] [Related]

  • 12. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ.
    BMC Psychiatry; 2005 Jan 13; 5():3. PubMed ID: 15649317
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct 13; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 14. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.
    J Clin Psychiatry; 2006 Oct 13; 67(10):1511-21. PubMed ID: 17107241
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug 13; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

  • 16. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.
    Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM.
    Qual Life Res; 1999 Aug 13; 8(5):417-26. PubMed ID: 10474283
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
    Ishigooka J, Inada T, Miura S.
    Psychiatry Clin Neurosci; 2001 Aug 13; 55(4):403-14. PubMed ID: 11442893
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.
    Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A.
    Int J Geriatr Psychiatry; 2003 Nov 13; 18(11):1013-20. PubMed ID: 14618553
    [Abstract] [Full Text] [Related]

  • 19. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR, Mahmoud R.
    Am J Psychiatry; 2001 May 13; 158(5):765-74. PubMed ID: 11329400
    [Abstract] [Full Text] [Related]

  • 20. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J, Gómez JC, García-Bernardo E, Cuesta M, Alvarez E, Gurpegui M.
    J Clin Psychiatry; 1997 Nov 13; 58(11):479-83. PubMed ID: 9413413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.